Search

Your search keyword '"de Wind, A"' showing total 3,900 results

Search Constraints

Start Over You searched for: Author "de Wind, A" Remove constraint Author: "de Wind, A"
3,900 results on '"de Wind, A"'

Search Results

52. Cancer survivors and adverse work outcomes

53. Return-to-work rates and predictors of absence duration after COVID-19 over the course of the pandemic

54. Machine-learning free-energy functionals using density profiles from simulations

58. A functional assay–based procedure to classify mismatch repair gene variants in Lynch syndrome

60. Unexpected moves

61. The slow de-implementation of non-evidence-based treatments in low back pain hospital care—Trends in treatments using Dutch hospital register data from 1991 to 2018

62. Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer

63. Contribution of mRNA Splicing to Mismatch Repair Gene Sequence Variant Interpretation

64. CNOT6: A Novel Regulator of DNA Mismatch Repair

65. Experiences with multiple job holding: a qualitative study among Dutch older workers

66. Predictors of working beyond retirement in older workers with and without a chronic disease - results from data linkage of Dutch questionnaire and registry data

70. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

71. Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions

72. Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer

73. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

74. Functional Th1-oriented T follicular helper cells that infiltrate human breast cancer promote effective adaptive immunity

75. HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study

76. Current practices, needs, and expectations of discussing work with a medical specialist from a patient's perspective: a qualitative study.

77. 5 things to consider before deciding to work for yourself

79. Why older workers work beyond the retirement age: a qualitative study

80. Predicting working beyond retirement in the Netherlands: an interdisciplinary approach involving occupational epidemiology and economics

81. 'Mental retirement?' Trajectories of work engagement preceding retirement among older workers

82. Predictive functional assay-based classification of PMS2 variants in Lynch syndrome

83. Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE

85. Arbeid over de grenzen heen

86. Discordant Staining Patterns and Microsatellite Results in Tumors of MSH6 Pathogenic Variant Carriers

87. Molecular Profile of MSH6-Associated Colorectal Carcinomas Shows Distinct Features From Other Lynch Syndrome–Associated Colorectal Carcinomas

88. Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

89. The slow de-implementation of non-evidence-based treatments in low back pain hospital care—Trends in treatments using Dutch hospital register data from 1991 to 2018

90. Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

91. Tumor Banks: A Quality Control Scheme Proposal

92. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

95. Patients' Experiences, Needs, and Expectations of Cooperation Between Medical Specialists and Occupational Health Physicians:A Qualitative Study

97. Table S3 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

98. Figure S1 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

99. Supplementary Methods from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues

Catalog

Books, media, physical & digital resources